Balloon vs stent: which works best for clogged leg arteries?
NCT ID NCT07277218
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two treatments for when a leg artery stent narrows again (in-stent restenosis). About 578 patients will receive either a drug-coated balloon or a drug-eluting stent, both of which release medication to keep the artery open. The goal is to see which approach reduces the need for repeat procedures over two years, helping doctors make better treatment decisions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
paclitaxel-coated balloon and paclitaxel-eluting stent
What this could lead to
If this study shows one treatment is clearly better, it could help doctors choose the most effective option for patients whose leg stents have narrowed again, reducing the need for repeat procedures.
What could go wrong
This is an observational study, not a randomized trial, so results may be influenced by how doctors choose treatments. It is also early-stage and may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FEMOROPOPLITEAL IN-STENT RESTENOSIS (ISR) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••